930 related articles for article (PubMed ID: 12912714)
1. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children.
Wald ER; Nash D; Eickhoff J
Pediatrics; 2009 Jul; 124(1):9-15. PubMed ID: 19564277
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of antimicrobial treatment for acute otitis media.
Tähtinen PA; Laine MK; Huovinen P; Jalava J; Ruuskanen O; Ruohola A
N Engl J Med; 2011 Jan; 364(2):116-26. PubMed ID: 21226577
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
Rakkar S; Roberts K; Towe BF; Flores SM; Heyd A; Warner J
Int J Clin Pract; 2001 Jun; 55(5):309-15. PubMed ID: 11452678
[TBL] [Abstract][Full Text] [Related]
6. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial.
Merenstein D; Whittaker C; Chadwell T; Wegner B; D'Amico F
J Fam Pract; 2005 Feb; 54(2):144-51. PubMed ID: 15689289
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
Feldman W; Sutcliffe T; Dulberg C
CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis.
Marple BF; Roberts CS; Frytak JR; Schabert VF; Wegner JC; Bhattacharyya H; Piccirillo JF; Sanchez SP
Am J Otolaryngol; 2010; 31(1):1-8. PubMed ID: 19944891
[TBL] [Abstract][Full Text] [Related]
10. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial.
Stalman W; van Essen GA; van der Graaf Y; de Melker RA
Br J Gen Pract; 1997 Dec; 47(425):794-9. PubMed ID: 9463979
[TBL] [Abstract][Full Text] [Related]
11. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
13. Amoxicillin/clavulanate in chronic rhinosinusitis: tissue and serum distribution.
Passàli D; Mazzei T; Novelli A; Fallani S; Dentico P; Mezzedimi C; Passàli GC; Bellussi L
Acta Otorhinolaryngol Belg; 2001; 55(3):259-64. PubMed ID: 11685965
[TBL] [Abstract][Full Text] [Related]
14. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
Riffer E; Spiller J; Palmer R; Shortridge V; Busman TA; Valdes J
Curr Med Res Opin; 2005 Jan; 21(1):61-70. PubMed ID: 15881476
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
Brook I
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
[No Abstract] [Full Text] [Related]
16. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
Klossek JM
Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
[TBL] [Abstract][Full Text] [Related]
17. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate.
Rechtweg JS; Moinuddin R; Houser SM; Mamikoglu B; Corey JP
Laryngoscope; 2004 May; 114(5):806-10. PubMed ID: 15126734
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis.
Arrieta JR; Galgano AS; Sakano E; Fonseca X; Amábile-Cuevas CF; Hernández-Oliva G; Vivar R; González G; Torres A;
Am J Otolaryngol; 2007; 28(2):78-82. PubMed ID: 17362810
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
File TM; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
